Transforming treatment of spina bifida with pioneering open fetal surgery February 2021 | By Neli Garbuzanova, Bernie Stocks, Dr Ayesha Ali, Fiona Marley, and Kate Steele Open spina bifida is a lifelong condition that occurs in about six in every 10,000 births.1 With clinical evidence pointing to improved outcomes for babies […]
COVID-19: impact on neonatal services February 2021 | By Tamsyn Crane Since the first cases of the novel coronavirus were seen in Wuhan, China, in December 2019,1 the whole world has been reeling from the effects […]
Using data to transform models of care February 2021 | By Johnny Skillicorn-Aston and Jeremy Hooper The NHS and other public services have a chequered history of using data in innovative ways. Now, more than ever before, we need to unlock […]
Pharmacogenomic testing for DPYD polymorphisms prior to fluoropyrimidine chemotherapy February 2021 | By Martin Bradley In November 2020, NHS England issued an urgent policy statement confirming the routine commissioning of pharmacogenomic testing prior to the initiation of fluoropyrimidine chemotherapy.1 This […]
Personalised medicine in the UK: the future is bright January 2021 | By Nina Buchan The 11th Pharmaceutical Industry Network Group (PING) Conference, UK life sciences— the future of genomics, personalised medicine, and AI, was held online on 26 November […]
The NHS must ‘adapt to adopt’ cell and gene therapies January 2021 | By Nina Buchan The Westminster Health Forum policy conference, Next steps for advanced therapies in the UK—research, innovation, and regulation, was held online on 9 September 2020. Matthew […]
